PRESS RELEASE published on 05/18/2026 at 21:30, 4 months 1 day ago Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD ElevAATe phase 2 study shows efdoralprin alfa surpassing traditional therapy in achieving and maintaining fAAT levels in AATD patients with emphysema. Results presented at 2026 ATS International Conference Efdoralprin Alfa ElevAATe FAAT Levels AATD Emphysema
PRESS RELEASE published on 05/18/2026 at 21:30, 4 months 1 day ago Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT Les données de l'étude de phase 2 ElevAATe démontrent la supériorité de l'efdoralprin alfa par rapport au traitement standard d'augmentation pour maintenir des taux normaux de fAAT chez les patients atteints d'emphysème lié au DAAT. Communiqué de presse présentant des résultats prometteurs lors de la conférence ATS 2026 Traitement DAAT Efdoralprin Alfa ElevAATe Emphysème
BRIEF published on 04/24/2026 at 20:35, 4 months 25 days ago Sanofi Prices €2.3 Billion in Bond Offering Corporate Finance Bond Issue Sanofi Fixed-rate Notes Euro Medium Term Note
BRIEF published on 04/24/2026 at 20:35, 4 months 25 days ago Sanofi fixe le prix de son émission obligataire à 2,3 milliards d'euros Emission D'obligations Finance D'entreprise Sanofi Billets À Taux Fixe Billet À Moyen Terme En Euros
PRESS RELEASE published on 04/24/2026 at 20:30, 4 months 25 days ago Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires Sanofi réalise une émission obligataire de 2,3 milliards d’euros en 3 tranches, afin de soutenir ses besoins généraux. Les obligations ont été placées avec succès grâce à la collaboration de différents coordinateurs globaux Émission Obligataire Sanofi Besoins Généraux Coordinateurs Globaux 2,3 Milliards
PRESS RELEASE published on 04/24/2026 at 20:30, 4 months 25 days ago Press Release: Sanofi successfully prices 2.3 billion of bond issue Sanofi successfully prices €2.3 billion bond issue with notes across 3 tranches under Euro Medium Term Note programme. Net proceeds for general corporate purposes Bond Issue Corporate Purposes Sanofi Euro Medium Term Note Global Coordinators
BRIEF published on 04/24/2026 at 12:14, 4 months 25 days ago Sanofi's Cenrifki Receives Positive CHMP Opinion for SPMS Sanofi HERCULES Study CHMP Recommendation Cenrifki Approval SPMS Treatment
BRIEF published on 04/24/2026 at 12:14, 4 months 25 days ago Cenrifki de Sanofi reçoit un avis favorable du CHMP pour SPMS Sanofi Étude HERCULES Approbation De Cenrifki Traitement De La SEP Progressive Secondaire Recommandation Du CHMP
BRIEF published on 04/24/2026 at 12:14, 4 months 25 days ago Sanofi obtient un avis favorable pour le tolebrutinib dans le traitement de la sclérose en plaques Sclérose En Plaques Sanofi Approbation Tolebrutinib CMUH
BRIEF published on 04/24/2026 at 12:14, 4 months 25 days ago Sanofi receives a favorable opinion for tolebrutinib in the treatment of multiple sclerosis Multiple Sclerosis Approval Sanofi Tolebrutinib CMUH
Published on 09/19/2026 at 00:55, 20 hours 58 minutes ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 22 hours 3 minutes ago Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 23 hours 53 minutes ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 day 1 hour ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 1 day 7 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/19/2026 at 16:40, 5 hours 12 minutes ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/19/2026 at 13:15, 8 hours 38 minutes ago Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO
Published on 09/19/2026 at 07:30, 14 hours 23 minutes ago Hong Kong sets out initiatives to secure long-term development of pillar industries
Published on 09/18/2026 at 18:44, 1 day 3 hours ago EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million
Published on 09/18/2026 at 18:34, 1 day 3 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 1 day 3 hours ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 17:45, 1 day 4 hours ago Communiqué de presse_Carrefour Bond_Septembre 2026